Video Experimental Relacionado
Updated: Jul 11, 2026
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Hielo: una nueva forma de dosificación de una vieja droga
Science (New York, N.Y.)
|August 10, 1990
Resumen
El hielo, una forma pura de clorhidrato de metanfetamina, plantea peligros significativos debido a su pureza y forma inhalable. Este potente psicoestimulante ofrece efectos prolongados, diferentes de la cocaína, y se sintetiza ilícitamente.
Área de la Ciencia:
- Farmacología Farmacología.
- La neurociencia es la neurociencia.
- Salud Pública La salud pública.
Sus antecedentes:
- El hielo es una forma altamente pura de clorhidrato de metanfetamina, que está emergiendo como una droga significativa de abuso.
- Su vía de administración por inhalación conduce a intensos efectos psicoestimulantes, comparables a las dosis intravenosas.
Objetivo del estudio:
- Para describir las características y peligros de Ice (hidrocloro de metanfetamina).
- Para comparar sus efectos y potencial de abuso con la cocaína.
Principales métodos:
- Revisión de la literatura existente sobre la metanfetamina y su abuso.
- Comparación farmacológica de los mecanismos de la metanfetamina y la cocaína y la duración de la acción.
Principales resultados:
- La pureza y la inhalabilidad del hielo aumentan su peligro y su potencial de abuso.
- Los efectos estimulantes de la metanfetamina son prolongados (horas) en comparación con la cocaína (minutos).
- La metanfetamina es un compuesto sintético fabricado en laboratorios ilegales nacionales.
Conclusiones:
- El hielo representa una forma peligrosa de abuso de metanfetamina, caracterizada por una alta pureza y la aparición rápida de efectos intensos y duraderos.
- Su perfil de abuso comparte similitudes con la cocaína, incluido el uso compulsivo, pero con un origen farmacocinético y sintético distinto.
- La fabricación doméstica ilícita de metanfetamina contribuye a su accesibilidad y amenaza la salud pública.
Videos de Conceptos Relacionados
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:28IV Infusion to Oral Dosing: Conversion Methods
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...